Rapid and reliable assessment of the contrast sensitivity function on an iPad

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 12, 2013, Pages 7266-7273

  Dorr, Michael ^a,b   Lesmes, Luis A ^a,b   Lu, Zhong Lin ^c   Bex, Peter J ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b Adaptive Sensory Technology   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Adaptive testing; Contrast sensitivity; Telemonitoring

Indexed keywords

ACCURACY; ADULT; ARTICLE; CLINICAL ASSESSMENT; COMMERCIAL TABLET DEVICE; CONTRAST SENSITIVITY; FEMALE; GENERAL DEVICE; HUMAN; HUMAN EXPERIMENT; MALE; MEASUREMENT REPEATABILITY; NORMAL HUMAN; OPTOMETRY; PHOTOMETER; PRIORITY JOURNAL; RELIABILITY; VALIDATION PROCESS; VISION; VISUAL STIMULATION;

ADAPTIVE TESTING; CONTRAST SENSITIVITY; TELEMONITORING;

ADULT; COMPUTERS, HANDHELD; CONTRAST SENSITIVITY; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VISION DISORDERS; VISION TESTS; YOUNG ADULT;

EID: 84887067496     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-11743     Document Type: Article

References (62)

1. Chopdar A, Chakravarthy U, Verma D. Age related macular degeneration. Br Med J. 2003;326:485-488.
2. Quigley HA. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
3. Silva PS, Cavallerano JD, Aiello LM, Aiello LP. Telemedicine and diabetic retinopathy: moving beyond retinal screening. Arch Ophthalmol. 2011;129:236-242.
4. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the united states. Arch Ophthalmol. 2006;124:1754-1760.
5. Sabour-Pickett S, Loughman J, Nolan JM, et al. Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab. J Ophthalmol. 2013;2013:1-7.
6. Ross JE, Bron AJ, Clarke DD. Contrast sensitivity and visual disability in chronic simple glaucoma. Br J Ophthalmol. 1984; 68:821-827.
7. Howes SC, Caelli T, Mitchell P. Contrast sensitivity in diabetics with retinopathy and cataract. Aust J Ophthalmol. 1982;10: 173-178.
8. Suñer IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. Invest Ophthalmol Vis Sci. 2009;50:3629-3635.
9. Shah N, Laidlaw AH, Shah SP, Sivasubramaniam S, Bunce C, Cousens S. Computerized repeating and averaging improve the test-retest variability of ETDRS visual acuity measurements: implications for sensitivity and specificity. Invest Ophthalmol Vis Sci. 2011;52:9397-9402.
10. Drum B, Calogero D, Rorer E. Assessment of visual performance in the evaluation of new medical products. Drug Disc Today Technol. 2007;4:55-61.
11. Csaky KG, Richman EA, Ferris FL. Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium. Invest Ophthalmol Vis Sci. 2008;49:479-489.
12. Owsley C. Contrast sensitivity. Ophthalmol Clin North Am. 2003;16:171-177.
13. Owsley C, Sloane ME. Contrast sensitivity, acuity, and the perception of "real-world" targets. Br J Ophthalmol. 1987;71: 791-796.
14. Rubin GS, Ng ESW, Bandeen-Roche K, Keyl PM, Freeman EE, West SK. A prospective, population-based study of the role of visual impairment in motor vehicle crashes among older drivers: the SEE study. Invest Ophthalmol Vis Sci. 2007;48: 1483-1491.
15. Lord SR, Dayhew J. Visual risk factors for falls in older people. J Am Geriatr Soc. 2001;49:508-515.
16. Hester AL, Wei F. Falls in the community: state of the science. Clin Interv Aging. 2013;8:675-679.
17. Kleiner RC, Enger C, Alexander MF, Fine SL. Contrast sensitivity in age-related macular degeneration. Arch Ophthalmol. 1988;106:55-57.
18. Freedman RD, Thibos LN. Contrast sensitivity in humans with abnormal visual experience. J Physiol. 1975;247:687-710.
19. Rolando M, Iester M, Macrí A, Calabria G. Low spatial-contrast sensitivity in dry eyes. Cornea. 1998;17:376-379.
20. Abrahamson M, Sjöstrand J. Impairment of contrast sensitivity function as a measure of disability glare. Invest Ophthalmol Vis Sci. 1986;27:1131-1136.
21. Stamper RL. The effect of glaucoma on central visual function. Trans Am Ophthalmol Soc. 1984;82:792-826.
22. Collins JW, Carney LG. Visual performance in high myopia. Curr Eye Res. 1990;9:217-223.
23. Gandolfi SA. Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma. Invest Ophthalmol Vis Sci. 2005;46:197-201.
24. Bodis-Wollner I. Visual acuity and contrast sensitivity in patients with cerebral lesions. Science. 1972;178:769-771.
25. Regan D, Raymond J, Ginsburg AP, Murray TJ. Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis. Brain. 1981;104:333-350.
26. Jindra LF, Zemon V. Contrast sensitivity testing: a more complete assessment of vision. J Cataract Refract Surg. 1989;15:141-148.
27. Woods RL, Wood JM. The role of contrast sensitivity charts and contrast letter charts in clinical practice. Clini Exp Optom. 1995;78:43-57.
28. Mosa ASM, Yoo I, Sheets L. A systematic review of healthcare applications for smartphones. BMC Med Inform Decis Mak. 2012;12:67.
29. Dosso AA, Bonvin ER, Morel Y, Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 1996; 234:300-305.
30. Fletcher D, Schuchard R. Visual function in patients with choroidal neovascularization resulting from age-related macular degeneration: the importance of looking beyond visual acuity. Optom Vis Sci. 2006;83:178.
31. Trevino R. Recent progress in macular function self-assessment. Ophthalmic Physiol Opt. 2008;28:183-192.
32. Richman J, Spaeth GL, Wirostko B. Contrast sensitivity basics and a critique of currently available tests. J Cataract Refract Surg. 2013;39:1100-1106.
33. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci. 1988;2: 187-199.
34. Rohaly AM, Owsley C. Modeling the contrast-sensitivity functions of older adults. J Opt Soc Am A. 1993;10:1591-1599.
35. Watson AB, Ahumada AJ. A standard model for foveal detection of spatial contrast. J Vis. 2005;5:717-740.
36. Lesmes LA, Lu ZL, Baek J, Albright TD. Bayesian adaptive estimation of the contrast sensitivity function: the quick CSF method. J Vis. 2010;10:17.1-17.21.
37. Kontsevich LL, Tyler CW. Bayesian adaptive estimation of psychometric slope and threshold. Vis Res. 1999;39:2729-2737.
38. Kujala J, Lukka T. Bayesian adaptive estimation: the next dimension. J Math Psychol. 2006;50:369-389.
39. Pesudovs K, Hazel CA, Doran RM, Elliott DB. The usefulness of Vistech and FACT contrast sensitivity charts for cataract and refractive surgery outcomes research. Br J Ophthalmol. 2004; 88:11-16.
40. Watson AB, Turano K. The optimal motion stimulus. Vision Res. 1995;35:325-36.
41. Li X, Lu ZL, Xu P, Jin J, Zhou Y. Generating high gray-level resolution monochrome displays with conventional computer graphics cards and color monitors. J Neurosci Methods. 2003; 130:9-18.
42. Munshi A, Ginsbur D, Shreine D. OpenGL ES 2.0 Programming Guide. Indianapolis, IN: Addison-Wesley Professional; 2008.
43. Allard R, Faubert J. The noisy-bit method for digital displays: converting a 256 luminance resolution into a continuous resolution. Behav Res Methods. 2008;40:735-743.
44. Applegate RA, Hilmantel G, Howland HC. Area under log contrast sensitivity function: a concise method of following changes in visual performance. Vis Sci Appl, Tech Digest Series. 1997;1:98-101.
45. American National Standards Institute. American National Standard for Ophthalmics: Multifocal Intraocular Lenses. Alexandria, VA: Optical Laboratories Association; 2007.
46. Hilz R, Cavonius CR. Functional organization of the peripheral retina: sensitivity to periodic stimuli. Vision Res. 1974;14: 1333-1337.
47. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135-160.
48. Van Nes FL, Koenderink JJ, Nas H, Bouman MA. Spatiotemporal modulation transfer in the human eye. J Opt Soc Am. 1967; 57:1082-1088.
49. Kooijman AC, Stellingwerf N, van Schoot EAJ, Cornelissen FW, van der Wildt GJ. Groningen edge contrast chart (GECKO) and glare measurements. In: Kooijman AC, Looijestijn PL, Welling JA, et al., eds. Low Vision. Lansdale, PA: IOS Press; 1994:101-110.
50. Wesolowski A, Eagle N, Tatem AJ, et al. Quantifying the impact of human mobility on malaria. Science. 2012;338:267-270.
51. Cho J, Lee H, Lim D, Kwon H, Yoon K. Mobile communication using a mobile phone with a glucometer for glucose control in type 2 patients with diabetes: as effective as an internet-based glucose monitoring system. J Telemed Telecare. 2009;15:77-82.
52. Nishiguchi S, et al. Reliability and validity of gait analysis by android-based smartphone. Telemed J E Health. 2012;18:292-296.
53. Sposaro F, Danielson G, Tyson T. iWander: an Android application for dementia patients. Conf Proc IEEE Eng Med Biol Soc. 2010:3875-3878.
54. Breslauer DN, Maamari RN, Switz NA, Lam WA, Fletcher DA. Mobile phone based clinical microscopy for global health applications. PLoS One. 2009;4:e6320.
55. Pamplona VF, Passos EB, Zizka J, et al. CATRA: interactive measuring and modeling of cataracts. In: SIGGRAPH '11: ACM Siggraph 2011 Papers. New York, NY: ACM; 2011:1-8.
56. Pamplona VF, Mohan A, Oliveira MM, Raskar R. NETRA: Interactive display for estimating refractive errors and focal range. ACM Trans Graphics-Proc ACM SIGGRAPH 2010. 2010;29:4, article 77.
57. Erickson GB, Citek K, Cove M, et al. Reliability of a computerbased system for measuring visual performance skills. Optometry. 2011;82:528-542.
58. Hou F, Huang CB, Lesmes L, et al. qCSF in clinical application: efficient characterization and classification of contrast sensitivity functions in amblyopia. Invest Ophthalmol Vis Sci. 2010; 51:5365-5377.
59. Ostrovsky Y, Andalman A, Sinha P. Vision following extended congenital blindness. Psychol Sci. 2006;17:1009-1014.
60. Kalia A, Lesmes L, Dorr M, et al. Measurements of contrast sensitivity functions show recovery from extended blindness. Perception ECVP. 2012;41(suppl):154.
61. Adams CP, Brantner VV. Spending on new drug development. Health Econ. 2010;19:130-141.
62. Lesmes L, Jackson ML, Bex P. Visual function endpoints to enable dry AMD clinical trials [published online ahead of print February 28, 2013]. Drug Discov Today Ther Strateg. doi:10. 1016/j.ddstr.2012.11.002.